Placing External Ventricular Drains Using Assistive Augmented Reality or Image-Based Localization
- Conditions
- ICH - Intracerebral HemorrhageTBI Traumatic Brain InjuryIVH- Intraventricular Hemorrhage
- Registration Number
- NCT07042048
- Lead Sponsor
- The Cooper Health System
- Brief Summary
The goal of this clinical trial is to assess if EVD placement using augmented reality is non inferior to image-guidance systems for assistance in adult patients needing an EVD for spontaneous ICH with IVH or severe TBI. The main question it aims to answer is:
Can EVDs be placed successfully with at least equal safety and efficacy using augmented reality devices in comparison to using standard image-guidance techniques?
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 50
- adult patient at time of screening
- diagnosis of spontaneous ICH with IVH with severe TBI
- Meet one or more of the following clinical or radiographic criteria:
Tissue swelling on imaging Dysmorphic ventricles on imaging Midline shift >2mm on imaging Mass effect on imaging Evans Index <0.3 on imaging Glasgow Coma Scale 3-8
- admitted to Cooper University Health
- requires an EVD
- Other concomitant intracranial pathology (e.g., tumor, tumor-related edema/hemorrhage, congenital condition, etc.)
- Concurrent participation in another research protocol for investigation of an experimental therapy
- Known or suspected inability to adhere to study protocol or protocol requirements, as per the discretion of the investigator
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Successful EVD catheter placement During procedure Post-procedural non-contrast head CT will be reviewed by masked assessor to evaluate success of EVD placement per the Kakarla grading system. This grading system classifies catheter positioning into three grades based on postoperative imaging. Grade 1 indicates optimal placement in the ipsilateral frontal horn or third ventricle for effective drainage. Grade 2 represents functional but non-ideal placement in the contralateral ventricle or non-eloquent cortex. Grade 3 denotes suboptimal placement in eloquent cortex or non-target spaces, potentially leading to complications. Thus, a higher score means a worse outcome.
rate of complication during placement During procedure
- Secondary Outcome Measures
Name Time Method rate of catheter tip dispositions During procedure number of passes for placement During procedure rate of AR or Stealth overlay failures on first try During procedure rate of EVD failure from placement to removal of EVD and assessed up to two weeks after EVD dislodgment of occlusion from placement to removal of EVD and assessed up to two weeks after rate of EVD replacement or revision During procedure rate of EVD associated hemorrhage from placement to removal of EVD and assessed up to two weeks after rate if EVD-associated infection from placement to removal of EVD and assessed up to two weeks after
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Cooper University Health
🇺🇸Camden, New Jersey, United States
Cooper University Health🇺🇸Camden, New Jersey, United StatesCorey Mossop, MDContact856-342-2000mossop-corey@cooperhealth.edu